What is Quatrofol (folate supplement)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Quatrofol?

Quatrofol is a branded form of (6S)-5-methyltetrahydrofolate (5-MTHF), which is the biologically active, reduced form of folate that the body can directly utilize without requiring metabolic conversion. 1

Chemical Structure and Classification

Quatrofol represents a specific formulation of 5-MTHF, which belongs to the folate family—a group of molecules that vary by oxidation state, one-carbon substitution groups (methyl, methylene, methenyl, formyl, formimino), and glutamate side-chain length. 1 Unlike synthetic folic acid, 5-MTHF is already in the reduced, bioactive form that functions as tetrahydrofolate in cellular metabolism. 1

Key Advantages Over Folic Acid

The primary clinical advantage of Quatrofol (5-MTHF) is that it bypasses the enzymatic conversion step required for folic acid, making it particularly valuable for individuals with MTHFR polymorphisms who cannot efficiently convert folic acid to its active form. 2

Specific benefits include:

  • Direct bioavailability: Does not require reduction by dihydrofolate reductase, the enzyme that converts folic acid to tetrahydrofolate 3, 4
  • Avoids unmetabolized folic acid (UMFA): Eliminates concerns about accumulation of unmetabolized folic acid in circulation, which can occur with supraphysiological doses of synthetic folic acid 2
  • Effective in enzyme deficiency: Works in patients with genetic polymorphisms affecting folate metabolism, particularly MTHFR variants 2

Clinical Applications

Quatrofol is primarily used in fertility support and pregnancy supplementation, where it offers superior safety and efficacy compared to folic acid. 2 The standard recommendation for neural tube defect prevention is 400 mcg daily for women of childbearing age. 1

Primary indications:

  • Preconception and pregnancy: Prevention of neural tube defects with equivalent or superior efficacy to folic acid 2
  • MTHFR polymorphism carriers: Individuals who cannot efficiently metabolize folic acid 2
  • Fertility enhancement: Supporting one-carbon metabolism essential for DNA synthesis and cell division 2

Biological Function

5-MTHF (the active component of Quatrofol) serves as a cofactor in one-carbon metabolism, which is required for:

  • DNA and RNA synthesis: Essential for purine and thymidylate production 1
  • Amino acid metabolism: Particularly homocysteine remethylation to methionine 1
  • Methylation reactions: Critical for gene expression and neurotransmitter synthesis 1

Safety Profile

Quatrofol has an excellent safety profile with minimal risk of toxicity at recommended doses, and unlike high-dose folic acid, does not carry the same concerns about masking vitamin B12 deficiency or causing neurological complications. 2 The upper tolerable limit for synthetic folic acid is 1 mg/day, established primarily to avoid masking B12 deficiency. 1 However, 5-MTHF formulations like Quatrofol may have different safety considerations since they don't accumulate as unmetabolized folic acid. 2

Important safety considerations:

  • No UMFA accumulation: Avoids potential deleterious effects of unmetabolized folic acid 2
  • B12 interaction: When supplementing with any folate form, concurrent B12 supplementation should be considered, especially in elderly populations 5
  • Drug interactions: Caution needed in patients on anticonvulsants, methotrexate, or other folate antagonists 4, 6

Dosing Context

While specific Quatrofol dosing depends on the formulation, standard folate recommendations apply:

  • General population: 330-400 mcg dietary folate equivalents daily 1
  • Pregnancy/lactation: Approximately 600 mcg daily (double the standard dose) 1
  • Neural tube defect prevention: 400-800 mcg daily periconceptionally 1
  • High-risk patients (prior NTD): 4 mg daily 1

The key distinction is that 5-MTHF (Quatrofol) is already bioactive, so dose equivalency with folic acid may differ based on individual metabolic capacity. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Folate: a key to optimizing health and reducing disease risk in the elderly.

Journal of the American College of Nutrition, 2003

Research

Folic acid and psychopathology.

Progress in neuro-psychopharmacology & biological psychiatry, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.